These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Human neutrophil alpha-defensins induce formation of fibrinogen and thrombospondin-1 amyloid-like structures and activate platelets via glycoprotein IIb/IIIa. Horn M; Bertling A; Brodde MF; Müller A; Roth J; Van Aken H; Jurk K; Heilmann C; Peters G; Kehrel BE J Thromb Haemost; 2012 Apr; 10(4):647-61. PubMed ID: 22268819 [TBL] [Abstract][Full Text] [Related]
6. A novel homozygous mutation (1619delC) in GPIIb gene associated with Glanzmann thrombasthenia, the decay of GPIIb-mRNA and the synthesis of a truncated GPIIb unable to form complex with GPIIIa. Losonczy G; Rosenberg N; Kiss C; Kappelmayer J; Vereb G; Kerényi A; Balogh I; Muszbek L Thromb Haemost; 2005 May; 93(5):904-9. PubMed ID: 15886807 [TBL] [Abstract][Full Text] [Related]
7. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo. Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956 [TBL] [Abstract][Full Text] [Related]
8. Safety of glycoprotein IIb-IIIa inhibitors: A heart surgeon's perspective. Dyke CM Am Heart J; 1999 Oct; 138(4 Pt 2):307-16. PubMed ID: 10502236 [TBL] [Abstract][Full Text] [Related]
9. PlA(1)/PlA(2) polymorphism does not influence response to Gp IIb-IIIa inhibitors in patients undergoing coronary angioplasty. Verdoia M; Pergolini P; Camaro C; Restifo M; Rolla R; Schaffer A; Di Giovine G; Marino P; Bellomo G; Suryapranata H; De Luca G; Blood Coagul Fibrinolysis; 2013 Jun; 24(4):411-8. PubMed ID: 23412353 [TBL] [Abstract][Full Text] [Related]
10. A point mutation in the cysteine-rich domain of glycoprotein (GP) IIIa results in the expression of a GPIIb-IIIa (alphaIIbbeta3) integrin receptor locked in a high-affinity state and a Glanzmann thrombasthenia-like phenotype. Ruiz C; Liu CY; Sun QH; Sigaud-Fiks M; Fressinaud E; Muller JY; Nurden P; Nurden AT; Newman PJ; Valentin N Blood; 2001 Oct; 98(8):2432-41. PubMed ID: 11588040 [TBL] [Abstract][Full Text] [Related]
11. Platelet transfusion enhances pro-aggregatory status shortly after coronary artery bypass grafting (CABG while modulating platelet pro-inflammatory state 1-week post-surgery. Ahmadi J; Hosseini E; Kargar F; Maghsudlu M; Ghasemzadeh M J Cell Mol Med; 2024 Aug; 28(15):e18573. PubMed ID: 39121235 [TBL] [Abstract][Full Text] [Related]
12. [Genetic risk factors for development of myocardial infarction in young men living in North-West region of Russia]. Pchelina SN; Sirotkina OV; Sheĭdina AM; Taraskina AE; Rodygina TI; Demina EP; Zabotina AM; Mitupova MI; Bazhenova EA; Berkovich OA; Shliakhto EV; Shvartsman AL; Shvarts EI Kardiologiia; 2007; 47(7):29-34. PubMed ID: 18260892 [TBL] [Abstract][Full Text] [Related]
13. The impact of genetic variation in the region of the GPIIIa gene, on Pl expression bias and GPIIb/IIIa receptor density in platelets. O'Halloran AM; Curtin R; O'Connor F; Dooley M; Fitzgerald A; O'Brien JK; Fitzgerald DJ; Shields DC Br J Haematol; 2006 Feb; 132(4):494-502. PubMed ID: 16412022 [TBL] [Abstract][Full Text] [Related]
14. Outcomes of patients with prior coronary artery bypass grafting and acute coronary syndromes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. Nikolsky E; McLaurin BT; Cox DA; Manoukian SV; Xu K; Mehran R; Stone GW JACC Cardiovasc Interv; 2012 Sep; 5(9):919-26. PubMed ID: 22995879 [TBL] [Abstract][Full Text] [Related]
15. Combined defect in membrane expression and activation of platelet GPIIb--IIIa complex without primary sequence abnormalities in myeloproliferative disease. Kaplan R; Gabbeta J; Sun L; Mao GF; Rao AK Br J Haematol; 2000 Dec; 111(3):954-64. PubMed ID: 11122160 [TBL] [Abstract][Full Text] [Related]
16. Classification of Iranian patients with Glanzmann's Thrombasthenia using a flow cytometric method. Farsinejad A; Abolghasemi H; Kazemi A; Aghaiipour M; Hadjati E; Faranoush M; Jazebi M; Ala F Platelets; 2011; 22(5):321-7. PubMed ID: 21526886 [TBL] [Abstract][Full Text] [Related]
17. Platelet inhibition and GP IIb/IIIa receptor occupancy by intracoronary versus intravenous bolus administration of abciximab in patients with ST-elevation myocardial infarction. Desch S; Siegemund A; Scholz U; Adam N; Eitel I; de Waha S; Fürnau G; Lurz P; Wetzel S; Schuler G; Thiele H Clin Res Cardiol; 2012 Feb; 101(2):117-24. PubMed ID: 22015616 [TBL] [Abstract][Full Text] [Related]